Clinical Trial Update: Growth Hormone and Chromosome 18q- and Abnormal Growth [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating growth hormone therapy for individuals with Loss of Chromosome 18q and growth hormone deficiency has completed. The update does not pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Loss of Chromosome 18q

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Loss of Chromosome 18q, Growth Hormone Deficiency | Phase 3 | Status: COMPLETED